Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($) $ in Thousands	Preferred stock Series X redeemable convertible preferred stock	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss	Total
Beginning balance at Dec. 31, 2022	$ 96,398	$ 28	$ 632,512	$ (507,643)	$ (79)	$ 221,216
Beginning balance (in shares) at Dec. 31, 2022	31,455	27,501,340
Increase (Decrease) in Shareholders' Equity
Issuance of common stock upon the conversion of preferred stock	$ (1,074)		1,074
Issuance of common stock upon the conversion of preferred stock (in shares)	(348)	57,910
Issuance of common stock upon exercise of options and warrants			37			37
Issuance of common stock upon exercise of options and warrants (in shares)		427,468
Stock-based compensation expense			1,220			1,220
Unrealized gain (loss) on short-term investments					75	75
Net Loss				(11,188)		(11,188)
Ending balance at Mar. 31, 2023	$ 95,324	$ 28	634,843	(518,831)	(4)	211,360
Ending balance (in shares) at Mar. 31, 2023	31,107	27,986,718
Beginning balance at Dec. 31, 2022	$ 96,398	$ 28	632,512	(507,643)	(79)	221,216
Beginning balance (in shares) at Dec. 31, 2022	31,455	27,501,340
Increase (Decrease) in Shareholders' Equity
Net Loss						(41,481)
Ending balance at Sep. 30, 2023	$ 95,324	$ 28	638,251	(549,124)		184,479
Ending balance (in shares) at Sep. 30, 2023	31,107	28,042,296
Beginning balance at Mar. 31, 2023	$ 95,324	$ 28	634,843	(518,831)	(4)	211,360
Beginning balance (in shares) at Mar. 31, 2023	31,107	27,986,718
Increase (Decrease) in Shareholders' Equity
Issuance of common stock upon exercise of options			273			273
Issuance of common stock upon exercise of options (in shares)		39,126
Stock-based compensation expense			1,331			1,331
Unrealized gain (loss) on short-term investments					4	4
Net Loss				(12,566)		(12,566)
Ending balance at Jun. 30, 2023	$ 95,324	$ 28	636,447	(531,397)		200,402
Ending balance (in shares) at Jun. 30, 2023	31,107	28,025,844
Increase (Decrease) in Shareholders' Equity
Issuance of common stock upon exercise of options			110			110
Issuance of common stock upon exercise of options (in shares)		16,452
Stock-based compensation expense			1,694			1,694
Net Loss				(17,727)		(17,727)
Ending balance at Sep. 30, 2023	$ 95,324	$ 28	638,251	(549,124)		184,479
Ending balance (in shares) at Sep. 30, 2023	31,107	28,042,296
Beginning balance at Dec. 31, 2023	$ 95,324	$ 41	728,285	(580,534)		243,116
Beginning balance (in shares) at Dec. 31, 2023	31,107	41,034,797
Increase (Decrease) in Shareholders' Equity
Issuance of common stock pursuant to an underwriting agreement, net of underwriter's discount and issuance costs		$ 10	117,162			117,172
Issuance of common stock pursuant to an underwriting agreement, net of underwriter's discount and issuance costs (in shares)		10,340,000
Issuance of common stock for at-the-market offerings, net of issuance costs		$ 3	19,999			20,002
Issuance of common stock for at-the-market offerings, net of issuance costs (in shares)		2,945,806
Issuance of common stock upon exercise of options and warrants		$ 1	4,632			4,633
Issuance of common stock upon exercise of options and warrants (in shares)		582,458
Stock-based compensation expense			2,754			2,754
Unrealized gain (loss) on short-term investments					(14)	(14)
Net Loss				(19,928)		(19,928)
Ending balance at Mar. 31, 2024	$ 95,324	$ 55	872,832	(600,462)	(14)	367,735
Ending balance (in shares) at Mar. 31, 2024	31,107	54,903,061
Beginning balance at Dec. 31, 2023	$ 95,324	$ 41	728,285	(580,534)		243,116
Beginning balance (in shares) at Dec. 31, 2023	31,107	41,034,797
Increase (Decrease) in Shareholders' Equity
Net Loss						(68,634)
Ending balance at Sep. 30, 2024	$ 95,324	$ 57	895,110	(649,168)	331	341,654
Ending balance (in shares) at Sep. 30, 2024	31,107	56,434,219
Beginning balance at Mar. 31, 2024	$ 95,324	$ 55	872,832	(600,462)	(14)	367,735
Beginning balance (in shares) at Mar. 31, 2024	31,107	54,903,061
Increase (Decrease) in Shareholders' Equity
Issuance of common stock upon exercise of options			94			94
Issuance of common stock upon exercise of options (in shares)		17,602
Stock-based compensation expense			3,451			3,451
Unrealized gain (loss) on short-term investments					(31)	(31)
Net Loss				(24,172)		(24,172)
Ending balance at Jun. 30, 2024	$ 95,324	$ 55	876,377	(624,634)	(45)	347,077
Ending balance (in shares) at Jun. 30, 2024	31,107	54,920,663
Increase (Decrease) in Shareholders' Equity
Issuance of common stock for at-the-market offerings, net of issuance costs		$ 2	15,241			15,243
Issuance of common stock for at-the-market offerings, net of issuance costs (in shares)		1,504,619
Issuance of common stock upon exercise of options			58			58
Issuance of common stock upon exercise of options (in shares)		8,937
Stock-based compensation expense			3,434			3,434
Unrealized gain (loss) on short-term investments					376	376
Net Loss				(24,534)		(24,534)
Ending balance at Sep. 30, 2024	$ 95,324	$ 57	$ 895,110	$ (649,168)	$ 331	$ 341,654
Ending balance (in shares) at Sep. 30, 2024	31,107	56,434,219